ISR, Immune System Regulation a small pharmaceutical company with a large appetite where they have very many different ideas and have five drug candidates who are in everything from the early preclinical phase to the clinical phase. This means that they have quite a wide range and a fairly large spread of risk, The chances of success in one or a couple of these different drug candidates are very high. It seems Bullish medium to long term in TA.